23:41 , May 3, 2017 |  BC Extra  |  Company News

Management tracks

Immunotherapy company GammaDelta Therapeutics Ltd. (London, U.K.) named Paolo Paoletti CEO, Natalie Mount CSO, and Dayle Hogg COO. Paoletti and Hogg both joined GammaDelta from Kesios Therapeutics Ltd. (London, U.K.), where Paoletti was CEO and...
08:00 , Feb 16, 2015 |  BioCentury  |  Product Development

The straight dopa

Laboratoires Pierre Fabre S.A. thinks the dopamine D3 receptor hypothesis of schizophrenia hasn't been fully tested yet because the compounds that failed earlier trials didn't engage enough of the receptors. To avoid that problem, the...
07:00 , Aug 4, 2014 |  BioCentury  |  Strategy

Guest Commentary: Biopharma's echo chamber

Of the many reasons for business failure, not listening to customers is the king. And too many biopharmas today are walking around wearing earplugs. In the U.S., managers are dealing with a set of increasingly...
07:00 , Jul 14, 2014 |  BC Week In Review  |  Company News

Nanosphere Inc, HealthTrust Purchasing Group L.P. sales and marketing update

Nanosphere signed an agreement with group purchasing organization HealthTrust to provide the company’s Verigene multiplex molecular diagnostics for infectious diseases to nearly 1,400 HealthTrust acute care facilities. The tests detect infections of the bloodstream, respiratory...
07:00 , May 19, 2014 |  BC Week In Review  |  Company News

MDxHealth, American Pathology Partners sales and marketing update

MDxHealth granted American Pathology Partners non-exclusive co-promotion rights in the U.S. to MDxHealth's ConfirmMDx for Prostate Cancer test. American Pathology Partners is a network of anatomic pathology laboratories. MDxHealth said there was no upfront payment...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Company News

GenoSpace, PathGroup, Thomson Reuters Corp. sales and marketing update

PathGroup, a private provider of pathology services, launched the SmartGenomics Heme Profile service. The offering provides oncologists with genomic profiling and information for patients that have failed or been unsuccessful on repeated therapy for leukemias,...
07:00 , May 13, 2013 |  BC Week In Review  |  Company News

Martindale Pharma sales and marketing update

Martindale launched Prenoxad Injection naloxone hydrochloride in the U.K. to treat acute opioid-related overdose. The product, which costs £18 ($28.05), is intended for emergency use for the complete or partial reversal of respiratory depression following...
07:00 , Mar 25, 2013 |  BC Week In Review  |  Clinical News

Microculture Kinetic diagnostic data

A study in blood and/or bone marrow aspirate samples from 109 previously untreated AML patients showed that DiaTech's MiCK assay results were significantly correlated with complete remission and OS outcomes for patients receiving standard induction...
08:00 , Jan 7, 2013 |  BC Week In Review  |  Company News

Access Genetics, Quest Diagnostics deal

On Dec. 31, 2012, Quest said it sold its OralDNA Labs salivary-diagnostics business to Access Genetics. Quest said the divestiture represents a step in the company's ongoing strategy to refocus its core diagnostic information services...
07:00 , Oct 1, 2012 |  BC Week In Review  |  Company News

DiaTech Oncology management update

DiaTech Oncology , Brentwood, Tenn.   Business: Cancer, Pharmacogenetics   Transitioned: Cary Presant to CMO from director of oncology  ...